news

Subscribe to our newsletter

Send us a link

'Post-normal' Science Requires Unorthodox Communication Strategies, Study Says

'Post-normal' Science Requires Unorthodox Communication Strategies, Study Says

Proposals to fight malaria by "driving" genes that slow its spread through mosquitoes is a high-risk, high-reward technology that presents a challenge to science journalists, according to a new report aimed at stimulating a fruitful, realistic public discussion of "post-normal" science and technology.

ETH-Präsident Reagiert Auf Mobbingfall: "Professoren Sollen Führungskurse Absolvieren"

ETH-Präsident Reagiert Auf Mobbingfall: "Professoren Sollen Führungskurse Absolvieren"

Der Mobbingfall an der ETH Zürich veranlasst den neuen Präsidenten Joël Mesot zu einer Massnahme.

Lab Severs Ties With James Watson, Citing 'Unsubstantiated and Reckless' Remarks

Lab Severs Ties With James Watson, Citing 'Unsubstantiated and Reckless' Remarks

In a recent documentary, the Nobel Prize-winning geneticist doubled down on comments he made a decade ago, then apologized for, regarding race, genetics and intelligence.

Editors of Informetrics Resign at Elsevier and Start New Journal

Editors of Informetrics Resign at Elsevier and Start New Journal

Today the entire editorial board of Informetrics, a major publication in the field of Scientometrics and Informetrics, has unanimously resigned their position. In the future they will dedicate their time to a new full open access journal: Quantitative Science Studies.

Ocean Warming Is Accelerating Faster Than Thought, New Research Finds

Ocean Warming Is Accelerating Faster Than Thought, New Research Finds

An analysis concluded that earth's oceans are heating up 40 percent faster on average than a United Nations panel estimated five years ago, a finding with dire implications for climate change.

Science and the Shutdown: 5 Things to Watch As US Impasse Drags on

Science and the Shutdown: 5 Things to Watch As US Impasse Drags on

A second wave of closures looms as the government funding fight barrels towards a record-breaking fourth week.

Scientists Despair As US Government Shutdown Drags on

Scientists Despair As US Government Shutdown Drags on

Space missions can continue to collect data, but thousands of federal researchers are forced to stay home without pay.

AI-enhanced Peer Review: Frontiers Launches Next Generation of Efficient, High-quality Peer Review

AI-enhanced Peer Review: Frontiers Launches Next Generation of Efficient, High-quality Peer Review

The integration of AIRA - Artificial Intelligence Review Assistant - into Frontiers' digital peer-review platform enables faster, more efficient quality control and manuscript handling.

Donald Trump Finally Has a White House Science Adviser

Donald Trump Finally Has a White House Science Adviser

Senate confirms meteorologist Kelvin Droegemeier to lead the White House Office of Science and Technology Policy.

Federal Shutdown Includes Agencies That Are Key Supporters of University Research

Federal Shutdown Includes Agencies That Are Key Supporters of University Research

Grant checks from NSF and other funders won't go out. Meetings on grant applications won't take place. Impact will grow with length of standoff. Trump threat on border with Mexico alarms some Texas campuses.

UC and Elsevier - Office of Scholarly Communication

UC and Elsevier - Office of Scholarly Communication

The University of California is re-negotiating its systemwide licenses with some of the world's largest scholarly journal publishers, including Elsevier, to provide additional open access options for UC authors. In these negotiations, the UC is seeking a single, integrated contract with each publisher that covers both the university's subscriptions and open access publishing of UC research in their journals - what are often known as "publish and read" agreements.

Max Planck Society Discontinues Agreement with Elsevier

Max Planck Society Discontinues Agreement with Elsevier

The Max Planck Society is going to discontinue their Elsevier subscription. By doing so the Society joins nearly 200 universities and research institutions in Germany who have already cancelled their agreements with Elsevier.

Elsevier Willing to Compensate Editors to Prevent Them from 'Flipping'

Elsevier Willing to Compensate Editors to Prevent Them from 'Flipping'

As some editors are moving to 'flip' their journal the publishing giant offers considerable compensations to change their minds.

Elsevier Acquires Science-Metrix Inc., Provider of Research Analytics Services and Data

Elsevier Acquires Science-Metrix Inc., Provider of Research Analytics Services and Data

Elsevier,  the information analytics business specializing in science and health, has acquired Science-Metrix Inc., a research evaluation firm that provides science research evaluation and analytics to assess science and technology activities

Discovered: The Most-Distant Solar System Object Ever Observed

Discovered: The Most-Distant Solar System Object Ever Observed

A team of astronomers has discovered the most-distant body ever observed in our Solar System. It is the first known Solar System object that has been detected at a distance that is more than 100 times farther than Earth is from the Sun. It was announced Monday by the International Astronomical Union's Minor Planet Center. Carnegie's Scott S. Sheppard, the University of Hawaii's David Tholen, and Northern Arizona University's Chad Trujillo made the discovery.

China Introduces 'Social' Punishments for Scientific Misconduct

China Introduces 'Social' Punishments for Scientific Misconduct

Offending researchers could face restrictions on jobs, loans and business opportunities under a system tied to the controversial social credit policy.

Ideation and Implementation of an Open Science Drug Discovery Business Model

Ideation and Implementation of an Open Science Drug Discovery Business Model

M4K Pharma was incorporated to launch an open science drug discovery program that relies on regulatory exclusivity as its primary intellectual property and commercial asset, in lieu of patents. In many cases and in key markets, using regulatory exclusivity can provide equivalent commercial protection to patents, while also being compatible with open science. The model is proving attractive to government, foundation and individual funders, who collectively have different expectations for returns on investment compared with biotech, pharmaceutical companies, or venture capital investors.In the absence of these investor-driven requirements for returns, it should be possible to commercialize therapeutics at affordable prices. M4K is piloting this open science business model in a rare paediatric brain tumour, but there is no reason it should not be more widely applicable.